In a world obsessed with software, Ionisos is building a €50M+ physical empire that makes medical innovation possible. They don't make devices—they make them safe enough to implant in humans.

"Ionisos isn't competing on brand—they're competing on physics. Gamma, e-beam, X-ray, Ethylene Oxide: they own every path to sterile."

The traffic data tells a story of a company that doesn't need hype. With 5,627 monthly visits and a global rank of #3.5M, they're not playing the traffic game. They're playing the contract game. Every visit is likely a qualified lead from a medical device company that needs sterilization yesterday. The 27% direct traffic is the smoking gun—these are repeat customers who type 'ionisos.com' directly into their browser because Ionisos is already their vendor of record.

• Multi-modal radiation approach (Gamma, e-beam, X-ray) means they can handle any device geometry or material constraint
• 12-site footprint creates a logistical advantage—customers can choose processing locations to minimize shipping costs and time
• Ethylene Oxide capability alongside radiation shows they cover the full spectrum, not just one tech bet